 |
||||||||||||||||||||||
U.C.L.A. Rheumatology Pathophysiology of Disease Course Lecture, |
||||||||||||||||||||||
 |
 |
|||||||||||||||||||||
   
|
Page 31 | |||||||||||||||||||||
Osteoporosis Page 31 |
 ......Index  Go to Previous page .....Go to Next page |
|||||||||||||||||||||
 |
other hand the use of HRT is associated with a significant reduction in heart disease. A comparison of the probabilities of various conditions with or without HRT is shown in figure 10. Therefore, there are several variables and issues that need to be taken into account when deciding with a patient whether HRT is appropriate i.e. does the patient have a positive family history for heart disease with several cardiac risk factors etc. | |||||||||||||||||||||
| Figure 9: Incidence and relative risk of breast cancer according to age and duration of HRT jpeg 560 x 480 pixels 22kbs excel | ||||||||||||||||||||||
 |
||||||||||||||||||||||
|
|
Page 31 | |||||||||||||||||||||
| Figure 10: Estrogen treatments and lifetime probabilities of selected conditions. jpeg 480 x 340 pixels 27kbs excel | ||||||||||||||||||||||
| ......Index Go to Previous page .....Go to Next page |
||||||||||||||||||||||
|
||||||||||||||||||||||
| About Us | Contact Us | ©2005 | This web site has been developed and maintained by Craig W. Wiesenhutter, M.D. | |||||||||||||||||||||